Purpose Neural EGF‐like 1 (Nell‐1), originally implicated in craniosynostosis, has been identified as a key regulator in osteogenic processes. While preclinical data were encouraging, clinical studies correlating serum Nell‐1 levels with osteoporosis remain scarce. This study aims to investigate the relationship between circulation Nell‐1 level and bone turnover markers, bone mineral density (BMD), bone microstructure, muscle strength, fall risk, and fractures in Chinese postmenopausal women. Methods Serum Nell‐1 levels were measured in 123 Chinese postmenopausal women. Muscle function was evaluated through grip strength tests, the Short Physical Performance Battery (SPPB), and the Timed Up and Go (TUG) test. Dual‐energy X‐ray absorptiometry was used to assess areal bone mineral density (aBMD), lumbar trabecular bone score (TBS), and muscle mass. High‐resolution peripheral quantitative computed tomography (HR‐pQCT) was applied to determine volumetric bone mineral density (vBMD), analyze bone microarchitecture, and estimate bone strength. Result Postmenopausal women with higher serum Nell‐1 levels had higher aBMD and total volumetric bone mineral density (Tot.vBMD) at the distal tibia, larger cortical area (Ct.Ar) and thicker cortical thickness (Ct.Th) at the distal tibia, and higher bone strength. There was a significant negative association between serum Nell‐1 levels and C‐terminal cross‐linking telopeptide of type I collagen (β‐CTX), while no significant correlations were observed between serum Nell‐1 levels and muscle mass or function. Conclusion Postmenopausal women with higher serum Nell‐1 levels exhibited higher BMD and bone strength, indicating its potential as a therapeutic invention for osteoporosis.
Gong et al. (2026) studied this question.